Meglena I Kandinska

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 6

Top Topics

Respiratory Syndrome Coronavirus

Structure Activity Relationship

Top Venues

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Xi Wang, Nikola T Burdzhiev, Hengrui Hu, Yufeng Li, Jiang Li, Vesela V Lozanova, Meglena I Kandinska, Man-Li Wang
Novel Tetrahydroisoquinoline-Based Heterocyclic Compounds Efficiently Inhibit SARS-CoV-2 Infection In Vitro . Viruses 15 (2) (2023)
Meglena I Kandinska, Nikola T Burdzhiev, Diana Valentinova Cheshmedzhieva, Sonia V Ilieva, Peter P Grozdanov, Neli Milenova Vilhelmova-Ilieva, Nadya Nikolova, Vesela V Lozanova, Ivanka Nikolova Nikolova
Synthesis of Novel 1-Oxo-2,3,4-trisubstituted Tetrahydroisoquinoline Derivatives, Bearing Other Heterocyclic Moieties and Comparative Preliminary Study of Anti-Coronavirus Activity of Selected Compounds. Molecules (Basel, Switzerland) 28 (3) (2023)
Meglena I Kandinska, Nikola T Burdzhiev, Diana Valentinova Cheshmedzhieva, Sonia V Ilieva, Peter P Grozdanov, Neli Milenova Vilhelmova-Ilieva, Nadya Nikolova, Vesela V Lozanova, Ivanka Nikolova Nikolova
Synthesis of Novel 1-Oxo-2,3,4-trisubstituted Tetrahydroisoquinoline Derivatives, Bearing Other Heterocyclic Moieties and Comparative Preliminary Study of Anti-Coronavirus Activity of Selected Compounds. Molecules (Basel, Switzerland) 28 (3) (2023)
Meglena I Kandinska, Nikola T Burdzhiev, Diana Valentinova Cheshmedzhieva, Sonia V Ilieva, Peter P Grozdanov, Neli Milenova Vilhelmova-Ilieva, Nadya Nikolova, Vesela V Lozanova, Ivanka Nikolova Nikolova
Synthesis of Novel 1-Oxo-2,3,4-trisubstituted Tetrahydroisoquinoline Derivatives, Bearing Other Heterocyclic Moieties and Comparative Preliminary Study of Anti-Coronavirus Activity of Selected Compounds. Molecules (Basel, Switzerland) 28 (3) (2023)
Xi Wang, Nikola T Burdzhiev, Hengrui Hu, Yufeng Li, Jiang Li, Vesela V Lozanova, Meglena I Kandinska, Man-Li Wang
Novel Tetrahydroisoquinoline-Based Heterocyclic Compounds Efficiently Inhibit SARS-CoV-2 Infection In Vitro . Viruses 15 (2) (2023)
Meglena I Kandinska, Nikola T Burdzhiev, Diana Valentinova Cheshmedzhieva, Sonia V Ilieva, Peter P Grozdanov, Neli Milenova Vilhelmova-Ilieva, Nadya Nikolova, Vesela V Lozanova, Ivanka Nikolova Nikolova
Synthesis of Novel 1-Oxo-2,3,4-trisubstituted Tetrahydroisoquinoline Derivatives, Bearing Other Heterocyclic Moieties and Comparative Preliminary Study of Anti-Coronavirus Activity of Selected Compounds. Molecules (Basel, Switzerland) 28 (3) (2023)